Expert consensus on the role of OM-85 in the management of recurrent respiratory infections: A Delphi study

References

• World Health Organization. Acute respiratory infections: the forgotten pandemic. Bull World Health Organ. 1998;76(1):1–9. Erratum in: Bull World Health Organ 1998;76(3):317. PMID: 9615503; PMCID: PMC2305630.
   Web of Science ®Google Scholar
• Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med. 2003 Feb 24;163(4):487–494. doi:10.1001/archinte.163.4.487. PMID: 12588210.
   PubMed Web of Science ®Google Scholar
• De Benedetto F, Sevieri G. Prevention of respiratory tract infections with bacterial lysate OM-85 bronchomunal in children and adults: a state of the art. Multidiscip Respir Med. 2013 May 22;8(1):33. doi:10.1186/2049-6958-8-33. PMID: 23692890; PMCID: PMC3679713.
   PubMed Web of Science ®Google Scholar
• West JV. Acute upper airway infections. Br Med Bull. 2002;61(1):215–230. doi:10.1093/bmb/61.1.215. PMID: 11997308; PMCID: PMC7110019.
   PubMedGoogle Scholar
• Williams BG, Gouws E, Boschi-Pinto C, Bryce J, Dye C. Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis. 2002 Jan;2(1):25–32. doi:10.1016/s1473-3099(01)00170-0. PMID: 11892493.
   PubMed Web of Science ®Google Scholar
• Marengo R, Ortega Martell JA, Esposito S. Paediatric recurrent ear, nose and throat infections and complications: can we do more? Infect Dis Ther. 2020 Jun;9(2):275–290. doi:10.1007/s40121-020-00289-3. Epub 2020 Apr 24. Erratum in: Infect Dis Ther. 2020 Sep;9(3):697-700. PMID: 32333286; PMCID: PMC7237599.
   PubMed Web of Science ®Google Scholar
• Gelardi M, Iannuzzi L, Trecca EMC, Kim B, Quaranta NAA, Cassano M. COVID-19: what happened to all of the otolaryngology emergencies? Eur Arch Otorhinolaryngol. 2020 Nov;277(11):3231–3232. doi:10.1007/s00405-020-06046-z. Epub 2020 May 18. PMID: 32424497; PMCID: PMC7233671.
   PubMed Web of Science ®Google Scholar
• Bell DM, Gleiber DW, Mercer AA, Phifer R, Guinter RH, Cohen AJ, Epstein EU, Narayanan M. Illness associated with child day care: a study of incidence and cost. Am J Public Health. 1989 Apr;79(4):479–484. doi:10.2105/ajph.79.4.479. PMID: 2929808; PMCID: PMC1349981.
   PubMed Web of Science ®Google Scholar
• Jiang X, Sun L, Wang B, Yang X, Shang L, Zhang Y. Health-related quality of life among children with recurrent respiratory tract infections in Xi’An, China. PLoS One. 2013;8(2):e56945. doi:10.1371/journal.pone.0056945. Epub 2013 Feb 25. PMID: 23451114; PMCID: PMC3581567.
   PubMed Web of Science ®Google Scholar
• Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 2008 Nov 18;6(11):e280. doi:10.1371/journal.pbio.0060280. PMID: 19018661; PMCID: PMC2586385.
   PubMed Web of Science ®Google Scholar
• Padem N, Glick Robison R. The infant and toddler with wheezing. Allergy Asthma Proc. 2019 Nov 1;40(6):393–395. doi:10.2500/aap.2019.40.4255. PMID: 31690378.
   PubMed Web of Science ®Google Scholar
• Stokes JR, Bacharier LB. Prevention and treatment of recurrent viral-induced wheezing in the preschool child. Ann Allergy Asthma Immunol. 2020 Aug;125(2):156–162. doi:10.1016/j.anai.2020.05.018. Epub 2020 May 23. PMID: 32454096.
   PubMed Web of Science ®Google Scholar
• Esposito S, Soto-Martinez ME, Feleszko W, Jones MH, Shen KL, Schaad UB. Nonspecific immunomodulators for recurrent respiratory tract infections, wheezing and asthma in children: a systematic review of mechanistic and clinical evidence. Curr Opin Allergy Clin Immunol. 2018 Jun;18(3):198–209. doi:10.1097/ACI.0000000000000433. PMID: 29561355; PMCID: PMC6037280.
   PubMed Web of Science ®Google Scholar
• Esposito S, Bianchini S, Bosis S, Tagliabue C, Coro I, Argentiero A, Principi N. A randomized, placebo-controlled, double-blinded, single-centre, phase IV trial to assess the efficacy and safety of OM-85 in children suffering from recurrent respiratory tract infections. J Transl Med. 2019 Aug 23;17(1):284. doi:10.1186/s12967-019-2040-y. PMID: 31443716; PMCID: PMC6708164.
   PubMed Web of Science ®Google Scholar
• Bianchini S, Argentiero A, Camilloni B, Silvestri E, Alunno A, Esposito S. Vaccination against paediatric respiratory pathogens. Vaccines (Basel). 2019 Nov 1;7(4):168. doi:10.3390/vaccines7040168. PMID: 31683882; PMCID: PMC6963365.
   PubMed Web of Science ®Google Scholar
• Scaglione F. Meccanismo d’azione ed efficacia di OM-85 nella prevenzione delle infezioni respiratorie. [OM-85 mechanism of action and efficacy in the prevention of the respiratory tract infections onset.]. Farmaci. 2017;16(1):1–8. Italian.
   Google Scholar
• Esposito S, Jones MH, Feleszko W, Martell JAO, Falup-Pecurariu O, Geppe N, Martinón-Torres F, Shen KL, Roth M, Principi N. Prevention of new respiratory episodes in children with recurrent respiratory infections: an expert consensus statement. Microorganisms. 2020 Nov 17;8(11):1810. doi:10.3390/microorganisms8111810. PMID: 33213053; PMCID: PMC7698530.
   PubMed Web of Science ®Google Scholar
• Rossi GA, Bessler W, Ballarini S, Pasquali C. Evidence that a primary anti-viral stimulation of the immune response by OM-85 reduces susceptibility to a secondary respiratory bacterial infection in mice. Ital J Pediatr. 2018 Sep 26;44(1):112. doi:10.1186/s13052-018-0569-7. PMID: 30257691; PMCID: PMC6158919.
   PubMedGoogle Scholar
• Orcel B, Delclaux B, Baud M, Derenne JP. Oral immunization with bacterial extracts for protection against acute bronchitis in elderly institutionalized patients with chronic bronchitis. Eur Respir J. 1994 Mar;7(3):446–452. doi:10.1183/09031936.94.07030446. PMID: 8013600.
   PubMed Web of Science ®Google Scholar
• Collet JP, Shapiro P, Ernst P, Renzi T, Ducruet T, Robinson A. Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS study steering committee and research group. prevention of acute respiratory infection by an immunostimulant. Am J Respir Crit Care Med. 1997 Dec;156(6):1719–1724. doi:10.1164/ajrccm.156.6.9612096. PMID: 9412546.
   PubMed Web of Science ®Google Scholar
• Solèr M, Mütterlein R, Cozma G, Swiss-German OM-85 Study Group. Double-Blind study of OM-85 in patients with chronic bronchitis or mild chronic obstructive pulmonary disease. Respiration. 2007;74(1):26–32. doi:10.1159/000093933. Epub 2006 Jun 12. PMID: 16772707.
   PubMed Web of Science ®Google Scholar
• Tang H, Fang Z, Saborío GP, Xiu Q. Efficacy and safety of OM-85 in patients with chronic bronchitis and/or chronic obstructive pulmonary disease. Lung. 2015 Aug;193(4):513–519. doi:10.1007/s00408-015-9737-3. Epub 2015 Jun 5. PMID: 26044556.
   PubMed Web of Science ®Google Scholar
• Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, Toppila-Salmi S, Bernal-Sprekelsen M, Mullol J, Alobid I, et al. European position paper on rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020 Feb 20;58(Suppl S29):1–464. doi:10.4193/Rhin20.600. PMID: 32077450.
   Google Scholar
• Li J, Zheng JP, Yuan JP, Zeng GQ, Zhong NS, Lin CY. Protective effect of a bacterial extract against acute exacerbation in patients with chronic bronchitis accompanied by chronic obstructive pulmonary disease. Chin Med J (Engl). 2004 Jun;117(6):828–834. PMID: 15198881.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Diseases. Pocket guide to COPD diagnosis, management, and prevention. A guide for health care professionals. 2021 report [accessed 2022 July 23]. https://goldcopd.org/wp-content/uploads/2020/11/GOLD-2021-POCKET-GUIDE-v1.0-16Nov20_WMV.pdf.
   Google Scholar
• Esposito S, Marchisio P, Prada E, Daleno C, Porretti L, Carsetti R, Bosco A, Ierardi V, Scala A, Principi N. Impact of a mixed bacterial lysate (OM-85 BV) on the immunogenicity, safety and tolerability of inactivated influenza vaccine in children with recurrent respiratory tract infection. Vaccine. 2014 May 7;32(22):2546–2552. doi:10.1016/j.vaccine.2014.03.055. Epub 2014 Mar 26. PMID: 24681270.
   PubMed Web of Science ®Google Scholar
• Esposito S, Bianchini S, Polinori I, Principi N. Impact of OM-85 given during two consecutive years to children with a history of recurrent respiratory tract infections: a retrospective study. Int J Environ Res Public Health. 2019 Mar 25;16(6):1065. doi:10.3390/ijerph16061065. PMID: 30934539; PMCID: PMC6466214.
   PubMed Web of Science ®Google Scholar
• Jones J, Hunter D. Consensus methods for medical and health services research. Bmj. 1995 Aug 5;311(7001):376–380. doi:10.1136/bmj.311.7001.376. PMID: 7640549; PMCID: PMC2550437.
   PubMed Web of Science ®Google Scholar
• Principi N, Di Cara G, Bizzarri I, Isidori C, Borgia P, Mignini C, Saponara M, Argentiero A, Esposito S. Prevention of invasive pneumococcal disease: problems emerged after some years of the 13-valent pneumococcal conjugate vaccine use. Curr Infect Dis Rep. 2018 Jan 24;20(1):1. doi:10.1007/s11908-018-0607-z. PMID: 29368250.
   PubMed Web of Science ®Google Scholar
• Principi N, Esposito S. Protection of children against influenza: emerging problems. Hum Vaccin Immunother. 2018 Mar 4;14(3):750–757. doi:10.1080/21645515.2017.1279772. Epub 2017 Mar 16. PMID: 28129049; PMCID: PMC5861800.
   PubMed Web of Science ®Google Scholar
• Ministero della Salute. Le Coperture vaccinali dell’età pediatrica e dell’adolescente. Italian; [accessed 2022 July 23]. https://www.salute.gov.it/imgs/C_17_tavole_20_allegati_iitemAllegati_3_fileAllegati_itemFile_7_file.pdf.
   Google Scholar
• Bonanni P, Angelillo IF, Villani A, Biasci P, Scotti S, Russo R, Maio T, Vitali Rosati G, Barretta M, Bozzola E, et al. Maintain and increase vaccination coverage in children, adolescents, adults and elderly people: let’s avoid adding epidemics to the pandemic: appeal from the board of the vaccination calendar for life in Italy: maintain and increase coverage also by re-organizing vaccination services and reassuring the population. Vaccine. 2021 Feb 22;39(8):1187–1189. doi:10.1016/j.vaccine.2020.10.024. Epub 2020 Dec 11. PMID: 33309482; PMCID: PMC7831710.
   PubMed Web of Science ®Google Scholar
• Colomé-Hidalgo M, Colomé-Hidalgo M, Campos JD, Gil de Miguel Á. Tracking the impact of the COVID-19 pandemic on routine infant vaccinations in the Dominican Republic. Hum Vaccin Immunother. 2022 Dec 31;18(1):1972708. doi:10.1080/21645515.2021.1972708. Epub 2021 Oct 13. PMID: 34644243; PMCID: PMC8920135.
   PubMed Web of Science ®Google Scholar
• Cao C, Wang J, Li Y, Li Y, Ma L, Abdelrahim MEA, Zhu Y. Efficacy and safety of OM-85 in paediatric recurrent respiratory tract infections which could have a possible protective effect on COVID-19 pandemic: a meta-analysis. Int J Clin Pract. 2021 May;75(5):e13981. doi:10.1111/ijcp.13981. Epub 2021 Jan 22. PMID: 33405321; PMCID: PMC7883224.
   PubMed Web of Science ®Google Scholar
• Jara-Pérez JV, Berber A. Primary prevention of acute respiratory tract infections in children using a bacterial immunostimulant: a double-masked, placebo-controlled clinical trial. Clin Ther. 2000 Jun;22(6):748–759. doi:10.1016/S0149-2918(00)90008-0. PMID: 10929921.
   PubMed Web of Science ®Google Scholar
• Razi CH, Harmancı K, Abacı A, Özdemir O, Hızlı S, Renda R, Keskin F. The immunostimulant OM-85 BV prevents wheezing attacks in preschool children. J Allergy Clin Immunol. 2010 Oct;126(4):763–769. doi:10.1016/j.jaci.2010.07.038. PMID: 20920766.
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Tarango MD, Berber A. Safety and efficacy of two courses of OM-85 BV in the prevention of respiratory tract infections in children during 12 months. Chest. 2001 Jun;119(6):1742–1748. doi:10.1378/chest.119.6.1742. PMID: 11399700.
   PubMed Web of Science ®Google Scholar
• Schaad UB. OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review. World J Pediatr. 2010 Feb;6(1):5–12. doi:10.1007/s12519-010-0001-x. Epub 2010 Feb 9. PMID: 20143206.
   PubMed Web of Science ®Google Scholar
• Yin J, Xu B, Zeng X, Shen K. Broncho-Vaxom in pediatric recurrent respiratory tract infections: a systematic review and meta-analysis. Int Immunopharmacol. 2018 Jan;54:198–209. doi:10.1016/j.intimp.2017.10.032. Epub 2017 Nov 16. PMID: 29154122.
   PubMed Web of Science ®Google Scholar
• Heintz B, Schlenter WW, Kirsten R, Nelson K. Clinical efficacy of Broncho-Vaxom in adult patients with chronic purulent sinusitis – a multi-centric, placebo-controlled, double-blind study. Int J Clin Pharmacol Ther Toxicol. 1989 Nov;27(11):530–534. PMID: 2693373.
   PubMedGoogle Scholar
• Gómez Barreto D, De la Torre C, Alvarez A, Faure A, Berber A. Seguridad y eficacia de OM-85-BV más amoxicilina/clavulanato en el tratamiento de la sinusitis subaguda y prevención de infecciones recurrentes en niños [Safety and efficacy of OM-85-BV plus amoxicillin/clavulanate in the treatment of subacute sinusitis and the prevention of recurrent infections in children]. Allergol Immunopathol (Madr). 1998 Jan-Feb;26(1):17–22. Spanish. PMID: 9585823.
   PubMedGoogle Scholar
• Zagar S, Löfler-Badzek D. Broncho-Vaxom in children with rhinosinusitis: a double-blind clinical trial. ORL J Otorhinolaryngol Relat Spec. 1988;50(6):397–404. doi:10.1159/000276020. PMID: 3068610.
   PubMed Web of Science ®Google Scholar
• Chen J, Zhou Y, Nie J, Wang Y, Zhang L, Shi Q, Tan H, Kong W. Bacterial lysate for the prevention of chronic rhinosinusitis recurrence in children. J Laryngol Otol. 2017 Jun;131(6):523–528. doi:10.1017/S0022215117000524. Epub 2017 Mar 20. PMID: 28318451.
   PubMed Web of Science ®Google Scholar
• Bitar MA, Saade R. The role of OM-85 BV (Broncho-Vaxom) in preventing recurrent acute tonsillitis in children. Int J Pediatr Otorhinolaryngol. 2013 May;77(5):670–673. doi:10.1016/j.ijporl.2013.01.009. Epub 2013 Feb 4. PMID: 23380631.
   PubMed Web of Science ®Google Scholar
• Caporali R, Carletto A, Conti F, D’Angelo S, Foti R, Gremese E, Govoni M, Iannone F, Pellerito R, Sinigaglia L. Using a modified Delphi process to establish clinical consensus for the diagnosis, risk assessment and abatacept treatment in patients with aggressive rheumatoid arthritis. Clin Exp Rheumatol. 2017 Sep-Oct;35(5):772–776. Epub 2017 Mar 3. PMID: 28281459.
   PubMed Web of Science ®Google Scholar